An observational study in Breast Cancer and Surgery, sponsored by Federation of Breast Diseases Societies. Completed at 1 site in Turkey. Open to female participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-07-31.
Sponsored by Federation of Breast Diseases Societies · Observational
A registry trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer with bone metastasis only. Previous reports of carefully selected patients presenting with stage IV breast cancer suggest that surgery on the primary tumor may result in improved survival, but this remains unproven. The early results of our ongoing trial MF07-01 trial (a phase III randomized controlled trial of breast cancer women with distant metastases at presentation who receive loco-regional treatment for intact primary tumor compared with those who do not receive such treatment) showed that patients with bone metastasis only have a trend toward improved survival with initial surgery.
This registry trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer with bone metastasis only. Previous reports of carefully selected patients presenting with stage IV breast cancer suggest that surgery on the primary tumor may result in improved survival, but this remains unproven. The early results of our ongoing trial MF07-01 trial (a phase III randomized controlled trial of breast cancer women with distant metastases at presentation who receive loco-regional treatment for intact primary tumor compared with those who do not receive such treatment) showed that patients with bone metastasis only have a trend toward improved survival with initial surgery. Our goal is to test if primary surgery improves overall survival in bone only metastasis.
12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.
This study's enrollment of 460 is above the median of 184 across 2,642 observational studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Federation of Breast Diseases Societies is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
All female patients diagnosed with de novo stage IV breast cancer
Exclusion Criteria:
Standart chemotherapy
Drug: Systemic therapy
Standart surgery
Procedure: Surgery
Standart chemotherapy followed by surgery
Procedure: Surgery · Drug: Systemic therapy
Surgery to primary tumor
Also known as: mastectomy, lumpectomy
Systemic therapy based on tumor phenotype
Also known as: Chemotherapy, hormone therapy, biphosphanetes
Overall survival
Years
Time frame: 5 years
Locoregional progression
Number
Time frame: 5 years
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Federation of Breast Diseases Societies